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Summary
Hematopoietic potential arises in mammalian embryos before adult-repopulating hematopoietic 
stem cells (HSCs). At E9.5, we show the first murine definitive erythro-myeloid progenitors 
(EMPs) have an immunophenotype distinct from primitive hematopoietic progenitors, maturing 
megakaryocytes and macrophages, and rare B cell potential. EMPs emerge in the yolk sac with 
erythroid and broad myeloid, but not lymphoid, potential. EMPs migrate to the fetal liver and 
rapidly differentiate including production of circulating neutrophils by E11.5. While the surface 
markers, transcription factors and lineage potential associated with EMPs overlap with those 
found in adult definitive hematopoiesis, they are present in unique combinations or proportions 
that result in a specialized definitive embryonic progenitor. Further, we find that ES cell -derived 
hematopoiesis recapitulates early yolk sac hematopoiesis, including primitive, EMP and rare B 
cell potential. EMPs do not have long term potential when transplanted in immunocompromised 
adults, but can provide transient adult-like RBC reconstitution.
Introduction
Hematopoiesis in the adult consists of multipotent hematopoietic stem cells (HSCs) that 
differentiate through increasingly lineage-restricted progenitors that are modulated to 
provide a plethora of mature blood cells. However, this paradigm does not hold for the early 
embryo, which must simultaneously create the hematopoietic system while meeting the 
demands of embryonic growth and tissue differentiation with expanding blood cell numbers 
and lineage complexity. Additionally, hematopoietic function is required prior to the 
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existence of HSCs in the mammalian embryo (Fujiwara et al., 1996; Kumaravelu et al., 
2002; Muller et al., 1994) necessitating the emergence of alternate sources of transient 
hematopoietic progenitors. The first wave of embryonic hematopoiesis creates a cohort of 
circulating "primitive" red blood cells that mature semi-synchronously in the bloodstream 
and can be distinguished from later fetal and adult “definitive” erythroid cells by their large 
size and embryonic globin expression (Palis, 2014 for review). Primitive erythroid cells are 
derived from a discrete wave of extraembryonic yolk sac progenitors temporally associated 
with megakaryocyte and macrophage potential (Palis et al., 1999; Tober et al., 2007). 
However, evidence in the mouse demonstrates that primitive hematopoiesis is not sufficient 
to support embryonic survival until HSCs are functional (Chen et al., 2011). In the mouse 
embryo, there is a second wave of yolk sac-derived hematopoiesis that consists of definitive 
erythroid, megakaryocyte, myeloid, and multipotent progenitors (Chen et al., 2011; Palis et 
al., 1999, Palis, 2001). These definitive erythro-myeloid progenitors ("EMPs") are thought 
to be the source of the thousands of definitive erythroid progenitors and precursors found in 
the murine fetal liver prior to HSC colonization (Perdiguero et al., 2014; Frame et al., 2013 
for review). Definitive erythroid progenitors (BFU-E) also first emerge in the yolk sac of 
human embryos and then are found in the fetal liver before HSCs (Frame et al., 2013 for 
review). In live zebrafish embryos, EMPs emerge distinct from both primitive erythropoiesis 
and HSCs (Bertrand et al., 2007). In the mouse, HSC-independent hematopoiesis is not only 
necessary, but sufficient to support the survival until birth of embryos lacking HSCs (Chen 
et al., 2011). Rare cells with lymphoid potential also arise before adult-transplantable HSCs, 
including HSC-independent B-1 cell progenitors and immature HSCs capable of becoming 
HSCs after ex vivo culture or when transplanted into specialized hosts (Arora et al., 2014; 
Kieusseian et al., 2012; Kobayashi et al., 2014; Yoder et al., 1997). However, the 
relationship of these cells with EMPs has not been resolved. The overlap in spatial and 
temporal emergence as well as shared immunophenotypic markers has hampered 
distinguishing the origin and contributions of these waves of embryonic hematopoiesis.
Here, we report an immunophenotype that distinguishes EMPs from maturing primitive 
erythroid cells, macrophages, and megakaryocytes, as well as early definitive hematopoietic 
progenitors with B cell or immature HSC potential. Utilizing this unique immunophenotype, 
EMPs were shown to emerge in the yolk sac with erythroid and broad myeloid potential, 
then migrate to the fetal liver and rapidly differentiate including the production of 
circulating neutrophils by E11.5. In adult hosts, EMP lack long-term potential, but are able 
to provide transient adult-like RBC reconstitution. Further, we found that ES cell-derived 
hematopoiesis recapitulates early yolk sac HSC-independent hematopoiesis, including 
distinct primitive, EMP and rare B cell potential.
Results
EMPs acquire a unique immunophenotype as they emerge in the yolk sac
The emergence of hematopoietic progenitors in the yolk sac and the AGM of the mouse 
embryo have been associated with kit+ CD41+ cells (Ferkowicz et al., 2003; Mikkola et al., 
2003; Mitjavila-Garcia et al., 2002). The E7.5 neural plate mouse conceptus contains only 
primitive hematopoietic progenitors (Palis et al., 1999) and lacks a distinct kithi population 
McGrath et al. Page 2
Cell Rep. Author manuscript; available in PMC 2015 July 03.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
(Fig. 1A). By E8.5, concurrent with the appearance of the first definitive hematopoietic 
colony-forming cells (CFCs), a small population of kithi CD41+ cells is detected in the yolk 
sac. A subset of E8.5 kithi CD41+ cells is also positive for CD16/32, an antibody that 
recognizes the low affinity FCγII/III receptors (Fig. 1A). Both CD16/32− positive and -
negative cell fractions contain definitive hematopoietic CFC activity, as defined by 
definitive erythroid or granulocyte potential, which are not contained in the primitive wave 
of hematopoiesis (Fig. 1B, Palis et al., 1999). At E8.5, primitive erythroid CFCs were 
localized to the kitlo CD41lo population, while macrophage potential, a component of both 
primitive and EMP hematopoietic waves, was present in kitlo and kithi populations. By E9.5, 
the kit+CD41+ population increased to more than one thousand cells per yolk sac, over 90% 
of which are CD16/32+ (Fig. 1A). At E9.5, we found that the erythroid, megakaryocyte and 
myeloid CFCs, including high proliferative potential progenitors (HPP-CFCs), were 
associated with the kit+CD41+CD16/32+ population (Fig. 1C). Thus, definitive EMP 
potential arises at E8.25 as a kithi CD41+ population and by E9.5, resides in a kithi 
CD41+CD16/32+ population.
E9.5 yolk sacs also contain hundreds of kit-negative cells expressing either CD41 or 
CD16/32 (Fig. 1D) that lack CFC potential (Fig. 1C), but express other cell surface markers 
consistent with maturing megakaryocytes (GP1bβ+ CD45−) or macrophages (F4/80+ 
CD45+), respectively (Fig. 1D). The lineage markers GP1bβ or F4/80 were not expressed on 
the kithi EMPs. The presence of hundreds of maturing megakaryocytes and macrophages at 
E9.5, when only a few EMPs are detected one day earlier, is consistent with their derivation 
from the hundreds of primitive hematopoietic progenitors that emerge in the yolk sac 
between E7.25 and E8.5. Taken together, our data indicate that by E9.5, the murine yolk sac 
contains several distinct populations of blood cells, which include maturing primitive 
erythroblasts, megakaryocytes, and macrophages, as well as an emerging population of 
definitive hematopoietic progenitors, EMPs, identified by their concurrent surface 
expression of kit, CD41 and CD16/32.
EMPs emerge in the yolk sac
Definitive hematopoietic progenitors are found in the embryo proper only after the onset of 
circulation (E8.25), and circulation-deficient mouse embryos lack definitive CFC in the 
embryo proper at E9.5 (Lux et al., 2008; Palis et al., 1999). However, other vascular beds, 
including the forming placenta and vitelline and umbilical vessels, have also been suggested 
as sites of early hematopoietic progenitor emergence (de Bruijn et al., 2000; Gordon-
Keylock et al., 2013). Therefore, we reassessed the spatial and temporal emergence of EMPs 
in the total conceptus, using the presence of primitive erythroblasts (EryP) to estimate the 
contribution of yolk sac-derived blood cells found circulating in tissues (McGrath et al., 
2003). At E9.5, immunophenotypic EMPs were enriched in the yolk sac, but not in the 
placenta or in extraembryonic vessels compared to the embryo proper (Fig. 1E). 
Additionally, EMPs emerged from cultured yolk sacs, but not chorion, allantois or embryo 
propers from pre-circulation embryos (Fig. 1F). Finally, immunophenotypic EMPs were 
found exclusively in the yolk sacs of E9.5 Ncx1-null circulation-deficient embryos (Fig. 
1G). Comparable numbers of EMPs, normally distributed throughout the embryo, were 
concentrated in the yolk sac of Ncx1-null embryos (Fig. 1G). This suggests that, unlike 
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HSCs (North et al., 2009), EMP commitment is independent of blood flow. We conclude 
that EMPs emerge predominately, if not entirely, in the yolk sac.
EMP emergence is associated with markers of hemogenic endothelium and a subset of 
markers expressed by HSCs
HSCs co-express endothelial markers and hematopoietic markers as they emerge from 
hemogenic endothelium and the first definitive erythroid potential migrating into the yolk 
sac arises from a hemogenic endothelial precursor (Huber, 2004; Swiers et al., 2013 for 
review). Likewise, E9.5 kit+ CD41+ EMPs express multiple endothelial and hematopoietic 
markers (Fig. 1H). Unlike HSCs, EMPs express CD16/32 but not Sca1 on their cell surface 
(Fig. 1H) or at the transcript level (data not shown). AA4.1, a marker of fetal liver HSCs 
(Petrenko et al., 1999), is detected on a small proportion of E9.5 EMPs, but this may be part 
of EMP’s endothelial marker expression. Unlike in the fetal liver, AA4.1 is expressed by 
E9.5 yolk sac endothelial cells (Ho et al., 2003), and the majority of AA4.1+ cells in E9.5 
yolk sacs are in the endothelial kitneg VE-Cadherin+ population (88+/− 2% of AA4.1+ cells). 
Taken together, our data indicate that EMPs share markers of hemogenic endothelial 
emergence with HSCs, but can be distinguished by expression of CD16/32 and lack of Sca1 
expression.
EMPs rapidly proliferate with extensive erythroid-myeloid potential
When E9.5 kit+CD41+CD16/32+ cells were cultured in medium that supports diverse 
myeloid potential (Arinobu et al., 2005), they proliferated more rapidly than bone marrow 
hematopoietic progenitors, increasing in number approximately 10,000 fold in 6 days (Fig. 
2A). This proliferation was associated with rapid maturation, as evidenced by loss of CFC 
activity and a large increase in hemoglobin-containing erythroid cells as well as 
megakaryocytes and myeloid cells visible by four days in culture (Figs. 2B and 2C). By 
seven days of culture, EMPs generated an extensive repertoire of cells with myeloid 
morphology (Fig. 2D) that expressed lineage-specific genes (Fig. 2E) including 
macrophages, neutrophils, basophils, eosinophils, and mast cells. Interestingly, EMPs 
exhibited a significantly different lineage bias compared to bone marrow progenitors, and 
generated more erythroid than myeloid cells. Within the myeloid lineage, EMPs also 
produced a higher percentage of F4/80+ monocyte/macrophages, particularly large F4/80hi 
macrophages, than GR-1hi granulocytes (Fig. 2F, S1).
Individual EMPs can generate both erythroid and myeloid cells, as observed when E9.5 
kit+CD41+CD16/32+ cells plated in semi-solid media generated Emix colonies with 
erythroid and myeloid cells (Fig. 2G). Furthermore, analysis of progeny from individual 
EMPs in liquid culture demonstrated that 17+/−4% EMPs had both erythroid and myeloid 
potential (Fig. 2H, S2). EMPs express many transcription factors that regulate hematopoietic 
lineage decisions in adults (Iwasaki et al., 2006; Orkin and Zon, 2008) and do so at levels 
intermediate between adult granulocyte-monocyte progenitors (GMPs) and megakaryocyte-
erythroid progenitors (MEPs), consistent with the observed erythroid and-myeloid potential 
of EMPs (Fig. 2I). High levels of GATA-1 and low expression of Gfi1 compared with adult 
GMPs also correlates with the predilection of EMPs to generate erythroblasts and 
macrophages.
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EMPs lack B cell potential
B cell potential independent of HSC formation has been identified in the E9.5 yolk sac 
coincident with EMP formation (Kobayashi et al., 2014). However, EMPs lack IL7R and 
Flt3 cell surface markers and Pax5 transcription factor expression, which are associated with 
lymphoid progenitors arising from HSCs (Fig. 1H, data not shown, Adolfsson et al., 2005). 
Furthermore, EMPs differentiated in vitro in IL7-containing media failed to express Rag2, 
unlike parallel cultures of adult LK cells (Fig. 2E). Primary purified EMPs cultured on an 
OP9 cell monolayer generated only myeloid and erythroid cells, while IL7R+ bone marrow 
progenitors rapidly generated CD19+B220+ cells (Fig. 3A and B). This short-term assay 
detects existing lymphoid progenitors, while extended cultures on OP9 stroma promotes 
emergence of lymphoid progenitors that then mature into B cells. As published (Yoshimoto 
et al., 2011), extended cultures of unfractionated E9.5 yolk sac cells differentiated at a low 
frequency into lymphoid progenitors by 12 days in culture (Fig. 3D), but when 
subfractionated B cell potential was present within the non-EMP fraction and absent in the 
EMP population, indicating that B cell potential emerges independently of EMPs in the E9.5 
yolk sacs (Fig. 3C, D).
Differentiating embryonic stem (ES) cells recapitulate yolk sac hematopoiesis
Similar to the embryo, the first hematopoietic cells that emerge during differentiation of 
mouse or human ES cells are primitive erythroblasts with associated macrophages and 
megakaryocytes, including a primitive MEP (Fujimoto et al., 2003; Keller et al., 1993; 
Klimchenko et al., 2009; Paluru et al., 2014). Definitive hematopoiesis subsequently 
emerges, but it remains unclear whether this represents the in vitro equivalent of HSC or 
EMP-derived definitive potential. We found that ES cells grown as embryoid bodies (EBs) 
generate a population of immunophenotypic EMPs coincident with the emergence of 
definitive CFCs (Fig. 4B). Furthermore, definitive CFCs were predominately associated 
with the EMP fraction, while primitive erythroid CFCs did not reside in this population (Fig. 
4C). As seen in yolk sacs, macrophage potential of EBs was associated with both primitive 
and EMP hematopoiesis. We next asked whether B cell potential arises independently of 
EMP during ES/EB differentiation by comparing EB-derived immunophenotypic EMPs 
with the remainder of EB cells that were additionally VE-cadherin positive (Non-EMP VEC
+) to enrich for possible B cell potential in this fraction (Yoshimoto et al., 2011). As in the 
yolk sac, B cell potential was distinct from the sorted EMP fraction (Fig. 4D and E). Thus, 
initial emergence of hematopoietic potential in ES/EBs appears to recapitulate the 
emergence of HSC-independent yolk sac hematopoiesis, consisting of a wave of primitive 
hematopoiesis followed by the emergence of distinct populations of EMP-definitive 
progenitors and a rarer population of cells with B cell potential.
EMPs migrate to the fetal liver and differentiate including production of neutrophils
At E10.5, when the liver is colonized with hematopoietic progenitors, EMPs were found in 
most tissues at a similar ratio to primitive erythroid cells in the peripheral blood, indicating 
their widespread presence in the circulation (Fig. 5A). EMPs remained enriched in the yolk 
sac above peripheral blood levels, as observed at E9.5, but were more highly enriched in the 
liver (Fig. 1E and 5A). This distribution of immunophenotypic EMPs mirrors that of 
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functional CFCs in E10.5 embryos (Palis et al., 1999). Additionally, the numbers of 
immunophenotypic EMPs and CFC in E10.5 blood and liver are similar and day 7 CFC 
activity was found predominately in sorted EMP (Fig. S3). After E10.5, there is a 
diminution of circulating EMPs, consistent with their egress into the fetal liver, although low 
numbers of circulating EMPs are still detected through E14.5, suggesting they may continue 
to colonize the fetal liver even as HSCs expand there (Fig. 5B).
We next asked whether the extensive in vitro myeloid potential of EMPs (Fig. 3D) is 
realized in the embryo. Wildtype females were mated to GFP+ males (UBC-GFP) so the 
resultant GFP+ fetal blood cells could be distinguished from any contaminating GFP− 
maternal cells. Rare embryonic granulocytes were detected in circulation as early as E11.5, 
and by E12.5, sorted GFP+ myeloid cells included those with neutrophil morphology (Figs. 
5C, 5D and 5E). Myelopoiesis was evident in the fetal liver by E11.5, with megakaryocytes 
and macrophages comprising the majority of the non-erythroid hematopoietic cells (Fig. 5F). 
While these lineage ratios are consistent with the in vitro potential of EMPs, early 
megakaryocytes and macrophages could also derive from primitive hematopoiesis. Thus, 
EMP myeloid fate is best confirmed by the emergence of granulopoiesis in the murine 
embryo. The fetal liver contained a similar range of granulocyte intermediates, as defined by 
GR-1 staining and cell size, present in the bone marrow (Figs. 5G and 5H), although with 
higher proportion of immature forms, as expected for onset and rapid expansion of 
granulopoiesis (Fig. 5I). Circulating granulocytes had neutrophil morphology (Fig. 5D for 
example), which agrees with a lack of detectable transcripts in the early fetal liver for 
eosinophil peroxidase (Epx) or a shared surface marker of basophils and mast cells (FCεR) 
(Fig. 5J). Additionally, consistent with a neutrophil identity, a significant oxidative burst in 
fetal GR-1+ cells was observed after stimulation with bacterial particles (Fig. 5K). These 
data provide evidence that the broad granulocyte potential of EMP in vitro is refined in the 
early fetus to the output of functional neutrophils.
EMPs engraft adult recipients and transiently generate red blood cells with adult-like 
characteristics
As EMP potential temporally overlaps with that of adult repopulating HSCs or immature 
HSCs, (Frame et al. 2013 for review), we asked whether EMPs contain long-term 
hematopoietic potential using UBC-GFP mice as donors to detect of reconstitution of 
erythrocytes and platelets as well as myeloid and lymphoid cells (Schaefer et al., 2001). 
Long-term reconstitution was not found when E10.5 EMPs were transplanted into normal 
adult recipients or when E9.5 or E10.5 EMPs were transplanted into immunocompromised 
mice either by intravenous or by intrafemoral injection (Fig. 6A). In contrast, E10.5 AGM or 
adult bone marrow cells provided long-term multilineage reconstitution. Therefore, like 
early B cell potential, EMPs are independent of early HSC potential in the embryo.
EMPs did, however, provide varying degrees of short-term reconstitution (Fig. 6A). 
Transplanted EMPs rapidly created a wave of circulating RBCs which persisted for weeks in 
the adult (Fig. 6B, Fig. S4). Reconstitution was usually limited to the erythroid lineage, with 
only occasional small numbers of myeloid cells or platelets detected. In the fetus, EMPs 
generate larger RBCs that express gamma globin in embryos transgenic for the human beta-
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globin locus (McGrath et al., 2011). Interestingly, in the reconstituted adult, EMP-derived 
RBCs were instead similar in size to adult RBCs (Fig. 6C and D). Additionally, EMPs 
transgenic for the human beta-globin locus generated RBCs in the adult that expressed 
predominately adult beta-globin (Fig. 6E). Thus, in the adult hematopoietic environment, 
EMPs retain their erythroid-biased short-term hematopoietic potential but generate mature 
erythrocytes with adult, rather than fetal, characteristics.
Discussion
The first blood cells in mammalian embryos consist of large nucleated "primitive" erythroid 
cells that arise from a transient wave of yolk sac progenitors. They are replaced in the fetus 
by smaller, enucleated red cells that were termed "definitive" more than a century ago 
(Maximov, 1909). Fetal and postnatal definitive RBCs were assumed to comprise one 
continuous lineage derived from HSCs. While there is clear evidence that this two-wave 
model is an oversimplification, the legacy of this model and its nomenclature still influences 
many interpretations of hematopoietic emergence. Primitive hematopoiesis is not restricted 
to erythroid cells, but is associated with macrophage and megakaryocyte potential (Palis et 
al., 1999; Paluru et al., 2014; Tober et al., 2007; Hoeffel et al. 2015). Our data have shown 
further that primitive and EMP-associated macrophage progenitors can be distinguished 
prospectively by immunophenotype. Consistent with a tri-lineage primitive hematopoietic 
potential, we and others have identified populations of maturing macrophages and 
megakaryocytes in the E9.5 yolk sac prior to formation of the fetal liver (Tober et al. 2007; 
Perdiguero et al. 2014; Hoeffel et al. 2015). The expression of CD41 and CD45 on these 
cells complicates the use of these markers in the identification of co-emerging definitive 
hematopoietic progenitors.
It has also become clear that along with the primitive hematopoietic potential, definitive 
blood cells also arise independently of HSC. In both human and mouse embryos, the first 
definitive erythroid progenitors emerge in the yolk sac before HSC arise and colonize the 
fetal liver prior to HSC (Frame et al. 2013 for review). While kit and CD41 mark both EMP 
and HSC emergence (Bertrand et al., 2005; Ferkowicz et al., 2003; Mikkola et al., 2003; 
Mitjavila-Garcia et al., 2002), we find that EMPs also become CD16/32+, a triple-positive 
immunophenotype without corollary in the adult hematopoietic hierarchy (Miyawaki et al., 
2014; Pronk et al., 2007). This phenotype made it possible to trace EMP emergence in the 
E8.5-9.5 yolk sac and their colonization of the fetal liver at E10.5-11.5. In contrast to the 
small numbers of adult transplantable and/or immature HSCs detected per embryo until 
E12.5, thousands of EMPs and hundreds of thousands of hematopoietic intermediates are 
detected during this time. These data complement lineage tracing experiments demonstrating 
yolk sac progenitors contribute significantly to fetal liver myelopoiesis (Perdiguero et al. 
2014; Hoeffel et al. 2015). While mouse embryos defective in HSC formation survive until 
birth, embryos with defects in primitive erythropoiesis die as early as E9.5, and those with 
defects in EMP-derived definitive erythropoiesis die by E15.5 (Chen et al., 2011; Fujiwara 
et al., 1996; Mucenski et al., 1991). Thus, the yolk sac provides erythroid and myeloid 
function through two distinct waves of progenitors that sequentially support embryogenesis 
until HSC-derived hematopoiesis is established at later stages of gestation.
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EMPs generate erythroid cells, megakaryocytes and a wide range of myeloid lineages in 
vitro. Our clonal analyses confirmed the presence of single EMPs with erythroid and 
myeloid potential, consistent with "common myeloid progenitors" (CMPs). However, there 
are important distinctions between EMPs and adult CMPs. In the adult, CD16/32 is 
expressed at low levels in CMPs and high levels in GMPs, which have lost erythroid and 
megakaryocyte potential (Akashi et al., 2000). Furthermore, adult murine CMPs can be 
subfractionated into a CD150+ population with mainly MEP potential and a CD150− 
population with mainly GMP potential (Pronk et al., 2007). In contrast, EMPs express high 
levels of CD16/32 and lack CD150 expression, yet are still strongly biased to generate 
erythroid cells and megakaryocytes. In vitro, EMPs are also biased to produce more 
macrophages than granulocytes, while CMPs preferentially form granulocytes (Akashi et al., 
2000). These in vitro lineage biases are consistent with their expression profile of 
transcription factors known to control adult erythro-myeloid lineage choice. This suggests 
that EMPs not only make definitive, or adult-like, blood cells, but may share transcriptional 
regulators with adult hematopoiesis in altered proportions that generate a hematopoietic 
progenitor specifically designed to meet the needs of the rapidly growing embryo.
Primitive hematopoietic progenitors and EMPs each generate megakaryocytes and 
macrophages. It has recently been demonstrated that yolk sac progenitors are an important 
source of multiple tissue-resident macrophages in the adult. Both primitive and EMP-
derived macrophages have been traced to different adult tissues. (Kierdorf et al., 2013; 
Perdiguero et al., 2014; Schulz et al., 2012; Ginhoux et al. 2010; Hoeffel et al. 2015). The 
first definitive erythroid and granulocyte potential in the mouse embryo are derived from 
EMPs and not from primitive hematopoiesis, and thus we used these lineages to specifically 
analyze EMP differentiation. Our previous studies demonstrated expanding definitive 
erythropoiesis in the fetal liver and the first definitive erythrocytes in the circulation by 
E11.5 (McGrath et al., 2011). Similarly, we report here that fetal granulocytes are present in 
the liver and bloodstream by E11.5 and then expand rapidly in both compartments. 
Interestingly, the wider granulocytic potential of EMPs is apparently narrowed to a 
neutrophil fate in the early fetus. Although we do not yet know if neutrophils have a role in 
mammalian embryogenesis, fetal neutrophils exhibited antibacterial oxidation responses 
consistent with a role in host defense. There are also possible roles for neutrophils in 
angiogenesis and niche interactions as seen in the adult (Casanova-Acebes et al., 2014; 
Christoffersson et al., 2012).
The emergence of lymphoid or long-term hematopoietic potential temporally overlaps with 
EMP emergence (Godin et al., 1995; Kieusseian et al., 2012; Kumaravelu et al., 2002; 
Yoder et al., 1997; Yoshimoto et al., 2011; Yoshimoto et al., 2012). While it is unclear how 
these latter potentials relate to one another, they have characteristics distinct from EMPs. 
Both lymphoid and nascent HSC emergences are more broadly distributed and considerably 
more rare than EMPs. However, the overlap in markers and timing could indicate they 
comprise a subset of EMPs. Our analysis of purified populations of EMPs demonstrated that 
early lymphoid and HSC potential are indeed distinct at E9.5. Taken together, these data 
indicate that the emergence of hematopoiesis in the embryo is remarkably complex, with 
distinct hematopoietic populations that have varied spatio-temporal emergence, abundance, 
lineage potential and persistence. It is important to note that our studies have focused on the 
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onset of hematopoiesis and prior to significant HSC expansion, so they do not rule out the 
possibility that hematopoietic progenitors continue to evolve in their phenotype or potential 
over time.
Ultimately, it will be important to determine how hematopoietic stem and progenitor cells 
with different lineage restrictions and self-renewal potential are generated in the developing 
embryo. ES and iPS cells are important experimental models of hematopoietic emergence 
with the promise of serving as a source of cell-based therapies. However, the absence of 
precise temporal and spatial cues makes it difficult to correlate findings in the ES/iPS 
system with those known to occur in the embryo. By comparing our observations in the 
embryo directly with those from differentiating ES cells, we found that ES cells 
recapitulated the hematopoietic development present in the yolk sac, including primitive 
hematopoietic, definitive EMP and rare B cell potential. This is not unexpected, given that 
these models mimic early embryogenesis and hematopoiesis generated from yolk sac 
progenitors account for almost all of the blood cells seen in the murine embryo from E7.5 to 
E12.5. The ability to identify and track yolk sac-derived hematopoietic lineages should 
facilitate future studies directing the development of ES/iPS cell systems beyond the yolk 
sac phase of hematopoietic emergence toward the formation of HSCs. Additionally, given 
their potential to provide short-term definitive erythrocytes, platelets and granulocytes, 
EMPs might also serve therapeutic roles. A better understanding of EMP will be critical to 
increase the cellular output and compatibility with the adult hematopoietic 
microenvironment.
Experimental Procedures
Mice, Tissue Collection and Processing
Mice were used in accordance with the guidelines of the University of Rochester School of 
Medicine and Dentistry Institutional Animal Care and Use Committee. Mice were 
maintained on 12-hour dark and light cycles. See supplemental experimental information for 
strains used. Mice were mated overnight and vaginal plugs examined in the morning (E0.3). 
Mice were sacrificed by CO2 narcosis. Embryonic tissues were isolated from staged 
embryos and dissociated as previously described (McGrath et al., 2011). Adult peripheral 
blood was collected from a tail or submandibular vein for analysis of reconstitution or was 
collected from the descending vena cava for terminal analysis. Femoral marrow was flushed 
and dissociated by trituration. For transplantation, cells were either injected in the tail vein 
or intrafemorally (Schmitz et al., 2011) into recipients pre-conditioned with 5Gy TBI for 
C57B6 and 1.5Gy TBI for NSG mice.
In Vitro Cultures
Colony forming assays for megakaryocyte progenitors, erythroid and myeloid progenitors 
and high proliferative potential progenitors were performed as previously described (Palis et 
al., 2001; Palis and Koniski, 2005). Embryonic tissues were explanted with two embryo 
equivalents in 100 ul of media as described (Shah et al., 2013). Sorted cells were cultured in 
maturation media (Arinobu et al., 2005) containing 20 ng/ml murine stem cell factor, IL-3, 
IL-6, and IL-7; 50 ng/ml IL-5 and IL-9; 10 ng/ml IL-11, granulocyte-macrophage colony-
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stimulating factor and thrombopoietin, (all Peprotech), and 2 U/ml erythropoietin (Amgen) 
at 105cells/ml or less. Short-term and long-term assays of B cell progenitors were performed 
as described (Yoshimoto et al., 2011).
ES/EB cells
PC13 embryonic stem cells (University of Rochester Transgenic Facility) and W4 cell lines 
(developed in the laboratory of Dr. Alex Joyner at NYU School of medicine) were cultured 
as EBs essentially as described (England et al., 2011) except that EBs were dissociated using 
collagenase type 1 according to manufacturer's instructions (Stemcell Technologies).
Cell staining and microscopy
Cytospun cells were stained using an automated Wright stain (Sigma) as described 
(Kingsley et al., 2004) or stained with standard Hematoxylin and Eosin (H&E) or 
acetylcholinesterase (ACE). Photomicroscopy was performed on a Nikon Eclipse 80i 
microscope using a 100X objective or for colonies a Nikon TE2000 and a 20x objective. 
Images were captured with a Nikon DS-Fi1 camera and minimally processed using Nikon 
Elements AR or Photoshop software.
PCR
For RT-PCR, RNA was extracted using RNeasy Plus Mini Kits (Qiagen), and cDNA 
synthesized utilizing SuperScript First-Strand Synthesis Systems (Invitrogen) according to 
manufacture's instructions. For quantitative RT-PCR, cDNA was made from sorted cells 
using the Cells to CT kit according to manufacturer's instructions (ABI). Primers and 
conditions are contained in supplemental experimental information. Expression levels were 
normalized to 18S transcript levels.
Flow Cytometry and Cell Sorting
Cells were blocked with 10% normal rat serum (Invitrogen) and then stained as indicated in 
experimental supplementary information with 1:100 dilutions of antibodies, vital DNA stain 
(10 uM DRAQ5 (eBioscience), or Vibrant Violet as recommended (Invitrogen) and live/
dead discriminator (1 ug/ml propidium iodide or 5 ug/ml DAPI: Invitrogen). Engraftment of 
RBC and platelets was assayed using 2 ul of whole blood and engraftment of myeloid cells 
was determined using 50 ul of blood analyzed after RBC lysis. Oxidative burst assay was 
performed after stimulation of cells with S. aureus bioparticles (Lifetechnologies) and 
detected utilizing dihydroethidium (DHE: Sigma) as reported (McFarlin et al., 2013). Cells 
were sorted using a FACS Aria or analyzed on an LSRII (BD Bioscience) using FlowJo 
analysis software (Treestar). Imaging flow cytometric data were collected on a 
ImageStreamX and analyzed using IDEAS 6.0 (Amnis).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
EMPs acquire a distinct cell surface phenotype as they emerge in the yolk sac. A. Analysis 
of yolk sac or bone marrow cells for expression of kit, CD41 and CD16/32. B. Distribution 
of CFCs in sorted E8.5 yolk sac cells. Def-CFCs represent the sum of colonies containing 
definitive erythroid cells and/or granulocytes (BFU-E, CFC-G, CFC-GM, or Emix). C. 
Hematopoietic potential of E9.5 yolk sac populations. D. Expression of megakaryocyte or 
macrophage surface markers on E9.5 yolk sac cells. Kit+(black), kit−CD16/32+ (blue), kit− 
CD41+ (red) populations (top graphs) were examined for maturation markers (bottom 
graphs). One example of three experiments with similar results is shown. E. Ratio of 
immunophenotypic EMPs versus circulating primitive erythroblasts in dissected E9.5 
conceptus. YS=yolk sac, EP= embryo proper, Pl= Placenta, VV and UV= viteline and 
umbilical vessels. F. Increases in definitive CFC in explanted E8.5 tissues after 48 hours. G. 
Numbers of immunophenotypic EMPs in Ncx1-null versus heterozygotes or wildtype E9.5 
tissues. H. Immunophenotype of kit+ CD41+ E9.5 yolk sac cells. Gating of positive cells 
was determined using a fluorescence minus one plus isotype negative control (FMO). In all 
graphs the average of 3 to 5 experiments is plotted +/− SEM.
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Figure 2. 
EMPs are multipotential progenitors that rapidly proliferate and differentiate into a wide 
variety of erythroid-myeloid cells. A. Increases in cell numbers relative to starting numbers 
in cultures of sorted EMPs or adult lineage negative kit+ cells (LKs). B. Loss of colony 
forming ability and accumulation of benzidine positive cells in the first 4 days of EMP 
culture. C. Morphology of cytospun cells generated by day 4 of maturation cultures of 
EMPs showing maturing erythroblasts (ery), megakaryocytes (mk), macrophages (m) and 
occasional neutrophils (n). Cells were stained with Wright's stain acetylcholinesterase 
(ACE) staining (bottom right) for megakaryocytes, size bar=25 um. D. Morphology of EMP 
progeny after 7 days. Cytospun cells stained with Wrights stain or H&E (bottom right). Size 
bar is 25 um. n=neutrophil, m=mast, b= basophil, e=eosinophil, mac= macrophage, 
ery=erythroblast. E. Erythroid, myeloid and lymphoid gene expression detected by RT-PCR 
in 7 day EMP and LK cultures. Genes expressed in macrophages (M-CSFR) neutrophils 
(PRTN3), mast cells (mMCP-5,FCεR), basophils (FCεR), megakaryocytes (GP1Bβ), 
erythroblasts (β1-globin) and lymphoid cells (Rag2) are shown. Representative example of 
three experiments is shown. F. Flow cytometric analysis of cells produced at day 6 of EMP 
and LK cultures with lineage specific markers comparing proportions of erythroid (Ter119+) 
versus myeloid (CD11b+) and monocyte/macrophage (F4/80+) versus granulocyte (GR-1+) 
within the CD11b+ fraction. Example of gated populations in Fig. S1. Average of 3 to 5 
experiments +/− SEM. The difference between percent EMP versus LK derived cells in each 
fraction was significant (p<0.001). G. E9.5 EMP-derived Emix colony and the cytospun 
cells within it (below) Size bars: top=200 um, bottom=25 um. H. Lineage combinations 
present after 6 days of liquid culture of individual E9.5 EMPs. Wells with robust growth 
(ranging from 10 to 20% of total wells) were analyzed by flow cytometry (see SI Fig. 1B). 
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All experiments were repeated 3 to 5 times to obtain the average +/− SEM. I. qPCR of 
transcription factor expression in sorted adult GMPs and MEPs normalized to levels found 
in sorted EMPs.
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Figure 3. 
E9.5 yolk sac B lymphoid potential is not derived from EMPs. A. Sorted E9.5 EMPs or bone 
marrow IL7R+ cells were cultured for 7 days on OP9 stroma and examined by flow 
cytometry for erythroid (Ter119+) myeloid (CD11b or GR-1+) or B lymphoid 
(B220+CD19+) markers. B. Quantitation of experiments in A. n=3 +/− SEM C. Potential to 
differentiate into B cell progenitors was examined in OP9 stromal co-culture with removal 
of non-adherent cells at 5 and 7 days and analysis at day 10 and 12 for B cells (AA4.1+ 
CD19+ B220+). D. Frequency of cultures that generated lymphoid progenitors after 12 days. 
Dissociated total yolk sac cells or cells with EMP immunophenotype or the remainder (Non-
EMP) were used. ee=embryo equivalent.
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Figure 4. 
Differentiation of ES cells generates temporal waves of hematopoiesis similar to the yolk 
sac. A. Emergence of a kit+CD41+CD16/32+ population during differentiation of ES cells as 
embryoid bodies (EBs). Example of day 8 EB from W4 ES cell line is shown. B. 
Representative examples of waves of definitive CFC (G-CFC, GM-CFC, BFU-E or Emix-
CFC) or primitive erythroid (EryP-CFC) and immunophenotypic EMPs during the 
maturation of two different lines of PC13 ES cells (top) or W4 ES Cells (bottom). Values 
are relative to maximum value seen per 105 EB cells during maturation. C. Distribution of 
CFC potential, definitive or primitive as defined in B as well as Mac-CFC in day 8 EB cells 
in immunophenotypic EMPs versus the rest of the cells (Non-EMP). Averages and SEM of 
4 experiments are shown. D. Potential of day 9 EB kit+CD41+CD16/32+ cells (EMP) or the 
VE-cadherin positive subpopulation of the remaining cells (Non-EMP VEC+) to 
differentiate into B-cell progenitors after 12 days of co-culture with OP9 stromal cells. 
Results from a negative culture started with EMPs and a positive culture of Non-EMP VEC
+ are shown. P13 ES cell line was used. B-cell potential was not observed in W4 ES cell line 
in parallel experiments although EMPs were still present.
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Figure 5. 
EMPs migrate to the fetal liver and differentiate including generation of mature neutrophils. 
A. Enrichment of EMPs in E10.5 tissues relative to circulating primitive erythroid cells 
(EryP). n=3 or 4 +/− SEM. *p<0.01, **p<0.003 B. Numbers of circulating 
immunophenotypic EMPs per embryo by flow cytometry. n=3 +/− SEM. C. Examples of 
imaging flow cytometry of peripheral blood from GFP+ E11.5 embryos. A nucleated 
primitive erythroblast is at the top of the images and the cell indicated by an asterisk is an 
embryonic granulocyte. Size bar=10 um D. Images of cytospun GFP+ Ter119-cells from 
E12.5 blood. Size bar =25 um E. Numbers of erythroid cells (Ter119+), macrophages 
(CD11b+F4/80+) and granulocytes (CD11b+ GR-1+) per embryo in circulation. Results from 
3 to 5 experiments +/− SEM. F. Numbers of erythroid cells, monocyte/macrophages and 
granulocytes per fetal liver were identified as in E. Megakaryocytes (Mk) were identified as 
kit− CD41+ with similar light scatter values as the other cells (to eliminate platelets). Results 
from 3 to 5 experiments +/− SEM. G. Analysis of granulocytes in bone marrow divided into 
early, mid, and late maturational stages based on cell size and the median pixel value for 
GR-1. Size bar=10um H. Images of maturing granulocytes from E12.5 liver. Size bar=10um 
I. Proportion of granulocytes in maturational stages as in G. n=3 +/− SEM. J. Expression of 
eosinophil (eosinophil peroxidase, Epx) or basophils and mast cells (FCεR1) transcripts as 
determined by RT-PCR in fetal liver samples and bone marrow. K. Analysis of oxidative 
burst in adult and E13.5 peripheral blood granulocytes after simulation with bacteria-like 
particles. Significance of induction in fetal p<10−4.
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Figure 6. 
EMPs engraft adult recipients and provide transient erythroid reconstitution. A. Frequency 
of mice with short-term (<8 weeks) and long-term reconstitution (>16 weeks) of blood cells 
after transplantation with sorted embryonic cells or bone marrow lin−kit+sca+ (LSK) into 
wildtype or NSG recipients. B. Example of erythroid reconstitution after injection of 4500 
E9.5 or 6000 E10.5 sorted EMPs or 200 bone marrow LSKs. C. Representative images of 
EMP-derived circulating definitive erythroid cells (E11.5 RBC-def) isolated from E11.5 
blood, and EMP-derived RBCs generated in an adult recipient and as well as recipient's 
endogenous RBCs. Size bar=10um. D. Diameter of RBCs as measured by imaging flow 
cytometry (height of Ter119 morphology mask). Average of 3 experiments are shown +/− 
SEM. E. Expression of human beta globin genes in transgenic EMP-derived cells 
transplanted into non-transgenic recipients (EMP Transplant) plotted as percent of total 
human beta globin message detected. Expression levels from tissues in transgenic mice are 
shown for comparison: primitive erythroblasts from peripheral blood (E11.5 Ery-Prim), 
EMP-derived erythroid cells sorted from E11.5 livers (E11.5 FL-Def) to remove circulating 
primitive erythrocytes (McGrath et al., 2011) as well as adult RBCs. Average of 3 samples 
+/− SEM is shown.
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